MSC Secretome and rTMS for Motor Recovery After Subacute Ischemic Stroke
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 205 participants.
Also called NCT07874269
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 205 participants
- Sponsor
- Jumraini Tammasse
- Registry
-
NCT07874269
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Indonesia
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07874269. Randomized; double masking; primary purpose treatment. Start 2026-11 (anticipated); primary completion 2027-07 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- MSC Secretome and rTMS for Motor Recovery After Subacute Ischemic Stroke
- Condition
- Ischemic Stroke
- Intervention (Biological)
- Mesenchymal Stem Cell-Derived Secretome
- Intervention (Device)
- Active Repetitive Transcranial Magnetic Stimulation
- Intervention (Drug)
- 0.9% Sodium Chloride Placebo
- Intervention (Device)
- Sham Repetitive Transcranial Magnetic Stimulation
- Lead sponsor
- Jumraini Tammasse
Record details
- Record id
cardio:ct-nct07874269- Content hash
ccd4268999baee35938b2aa62e8a255171526302803a38571cc4d6d8c79a332e